Retrospective Cohort Study
Copyright ©The Author(s) 2021.
World J Gastrointest Surg. Feb 27, 2021; 13(2): 164-175
Published online Feb 27, 2021. doi: 10.4240/wjgs.v13.i2.164
Table 1 Study cohort
Demographic factorsCRC patients < 50 yr of age, n (%)CRC patients ≥ 50 yr of age, n (%)P value
Total number (%)70 (17)341 (83)-
Gender
Male44 (62.9)209 (61.3)0.89
Female26 (37.1)132 (38.7)
BMI (kg/m2)
Median (IQR)24.7 (22.9-27)25 (22.4-28.9)0.3
NA724
Obesity (BMI > 30kg/m2)7 (10)60 (21.3)0.154
Inflammatory bowel disease13 (4.2)6 (1.8)0.19
Hereditary CRC Syndrome25 (7.1)7 (2.1)0.04a
Neoadjuvant Treatment17 (24.3)65 (19.1)0.33
ASA Class
I7 (11.3)9 (2.9)< 0.01b
II43 (69.4)182 (58.9)
III9 (14.5)110 (35.6)
IV3 (4.8)8 (2.6)
NA832
High-risk drinking3
Yes3 (4.8)48 (15.4)0.03a
No60 (95.2)267 (84.8)
NA7 26
Current smoker0.52
Yes18 (28.6)76 (24.1)
No45 (71.4)239 (75.9)
NA726
Preoperative albumine level (g/L)
Median (IQR)41.5 (37.3-45)38.5 (33-42)< 0.01b
NA32159